Can-Fite BioPharma Ltd. Operating Cash Flow
Can-Fite BioPharma Ltd. (CANF) reported Operating Cash Flow of -$8.95 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-03-26
| Period end | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -$8.95M 20-F · filed 2026-03-26 | ||
| 2025-06-30 | -$4.75M 6-K · filed 2025-08-28 | ||
| 2024-12-31 | -$7.64M 20-F · filed 2026-03-26 | ||
| 2024-06-30 | -$4.04M 6-K · filed 2025-08-28 | ||
| 2023-12-31 | -$8.44M 20-F · filed 2026-03-26 | ||
| 2023-06-30 | -$5.04M 6-K · filed 2024-08-29 | ||
| 2022-12-31 | -$10.80M 20-F · filed 2025-04-14 | ||
| 2022-06-30 | -$6.08M 6-K · filed 2023-08-31 | ||
| 2021-12-31 | -$9.86M 20-F · filed 2024-03-28 | ||
| 2021-06-30 | -$3.47M 6-K · filed 2022-08-25 | ||
| 2020-12-31 | -$12.06M 20-F · filed 2023-03-30 | ||
| 2020-06-30 | -$8.49M 6-K · filed 2021-08-26 | ||
| 2019-12-31 | -$11.08M 20-F · filed 2022-03-24 | -$10.83M 6-K · filed 2020-06-01 | |
| 2019-06-30 | -$5.58M 6-K · filed 2020-08-27 | ||
| 2018-12-31 | -$4.16M 20-F · filed 2021-03-25 | ||
| 2017-12-31 | -$8.97M 6-K · filed 2020-06-01 |